Key facts
- Notable investors include YuanBio Venture Capital, Alan Asset Management.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Maijie Life Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Maijie Life Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maijie Life Science
Developer and provider of natural porous hydroxyapatite and collagen-based regenerative materials designed for orthopedics, sports medicine, dental, and aesthetic industries. The company offers innovative, biocompatible repair and filling materials, providing healthcare and aesthetic industry users with advanced solutions for clinical challenges.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2017
- Ownership
- Privately Held (backing)
Maijie Life Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maijie Life Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maijie Life Science in its N-PORT filings yet. We sweep new filings monthly.